Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
C

Cadillac Ventures Inc
XTSX:CDC

Watchlist Manager
Cadillac Ventures Inc
XTSX:CDC
Watchlist
Price: 0.05 CAD
Market Cap: CA$2.5m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-84%
5Y
-84%
10Y
-
Liabilities
+
3Y
-1%
5Y
-23%
10Y
-
Equity
+
3Y
-91%
5Y
-90%
10Y
-

Balance Sheet Decomposition
Cadillac Ventures Inc

Balance Sheet
Cadillac Ventures Inc

Rotate your device to view
Balance Sheet
Currency: CAD
May-2011 May-2012 May-2013 May-2014 May-2015 May-2016 May-2017 May-2018 May-2019 May-2020
Assets
Cash & Cash Equivalents
0
1
1
0
0
0
1
0
0
0
Cash
0
1
0
0
0
0
1
0
0
0
Cash Equivalents
0
0
1
0
0
0
0
0
0
0
Short-Term Investments
3
0
0
0
0
0
1
1
0
0
Total Receivables
1
2
1
0
0
0
0
0
0
0
Accounts Receivables
1
0
0
0
0
0
0
0
0
0
Other Receivables
0
2
0
0
0
0
0
0
0
0
Total Current Assets
4
3
2
1
0
0
2
1
1
0
PP&E Net
19
20
21
22
22
22
22
23
18
4
PP&E Gross
19
20
21
22
22
22
22
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
1
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
24
N/A
24
-1%
23
-1%
23
0%
23
-2%
23
+1%
24
+4%
24
0%
20
-18%
5
-77%
Liabilities
Short-Term Debt
0
0
0
0
0
0
0
0
1
1
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
1
2
1
1
2
2
1
1
2
2
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
1
Total Liabilities
2
N/A
2
+24%
1
-55%
2
+85%
3
+54%
2
-4%
2
-25%
2
-8%
2
+26%
3
+25%
Equity
Common Stock
22
27
29
29
29
29
30
31
31
31
Retained Earnings
9
15
6
7
9
9
8
9
14
30
Additional Paid In Capital
8
9
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
22
N/A
22
-3%
23
+5%
22
-4%
20
-6%
21
+2%
22
+7%
22
+0%
18
-22%
2
-89%
Total Liabilities & Equity
24
N/A
24
-1%
23
-1%
23
0%
23
-2%
23
+1%
24
+4%
24
0%
20
-18%
5
-77%
Shares Outstanding
Common Shares Outstanding
11
12
16
17
6
10
24
30
30
30

See Also

Summary
CDC intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDC stock valuation using valuation multiples.
Wall Street Estimates
CDC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 320,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.